在严重的社区获得性肺炎患者中,肺部和肠道微生物群的分析:一项前性试点研究
Wei Zou1, Ruobin Zheng1,2, Sheng Lin1
1Department of Respiratory and Critical Care Medicine, Fuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
肺部和肠道微生物组在幸存下来的严重社区获得性肺炎 (SCAP) 患者和没有幸存的患者之间有所不同. 在SCAP患者中,特定的微生物模式与疾病严重程度和炎症标志物相关.
科学领域:
- 微生物组研究的研究.
- 宿主-病原体相互作用
- 临床微生物学 临床微生物学
背景情况:
- 肠道和肺部的微生物组对于宿主防御至关重要,并且可以预测严重的社区获得性肺炎 (SCAP) 的结果.
- 对SCAP患者肺部和肠道微生物景观的同时分析尚未得到充分理解.
- 这项研究研究了SCAP患者的肺和肠道微生物组合,比较了幸存者和非幸存者.
研究的目的:
- 为了研究SCAP患者肺部和肠道微生物群的同时景观.
- 识别能够预测临床参数和结果的微生物特征.
- 为了比较幸存下来的SCAP患者和死亡的SCAP患者之间的微生物组成.
主要方法:
- 对50名SCAP患者进行前性观察性研究.
- 使用16S rRNA基因测序对50个呼吸道和50个便样本进行分析.
- 在生存和死亡组之间比较微生物组组成,多样性和与临床参数的相关性.
主要成果:
- 死亡组显示阿尔法多样性减少,特别是在肺微生物群中.
- 特定的肺类 (Bacteroidales,Streptococcus) 和肠类 (Anaerotruncus,Peptacetobacter,Rutheniibacterium) 在生存组中得到了丰富.
- 某些肺和肠道细菌与炎症标志物 (PCT,CRP,中性粒细胞百分比) 和氧化水平 (PaO2 / FiO2) 相相关.
结论:
- 肺部和肠道微生物群中的独特微生物配置与SCAP患者的临床结果有关.
- 识别这些微生物模式可以为SCAP患者提供有针对性的干预措施.
- 微生物组分析有可能改善SCAP患者的治疗结果.
更多相关视频
09:24Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy
Published on: November 29, 2017
11:23Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia II: Pathophysiology
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
